SEC Form 4 · accession 0001209191-17-037518
Intellia Therapeutics, Inc. · NTLA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Perry A Karsen
Director
Period of report
Jun 1, 2017
Accepted (ET)
Jun 5, 2017 · 8:01 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001652130
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 1, 2017 | A | 5,000 | $11.985 | A | 5,000 | D |
Table II — derivative securities
No Table II lines on this filing.